English | Español
Patient Daily reports | Feb 15, 2021

NeuroRx CEO says Zyesami trial shows promising results for critically ill COVID-19 patients
Bree Gonzales | Feb 12, 2021

Aviptadil helped doctor who contracted COVID-19 avoid lung transplant
Bree Gonzales | Feb 12, 2021

Great Plains Health patients treated with Zyesami (aviptadil) show signs of recovery from COVID-19
Press release submission | Feb 12, 2021

ROCHE: Receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients
Press release submission | Feb 12, 2021

CARE CAP PLUS: Offers Solution to Benefit Patients and Doctors
Bree Gonzales | Feb 12, 2021

Zyesami (Aviptadil) helped speed recovery for GPH COVID patient
Patient Daily reports | Feb 3, 2021

Promising drug helps Florida man with COVID-19
Michael Pineda | Jan 10, 2021

Pandemic changes the way medical officials approach diabetes

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day